You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Iothalamate meglumine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for iothalamate meglumine and what is the scope of freedom to operate?

Iothalamate meglumine is the generic ingredient in five branded drugs marketed by Liebel-flarsheim and Mallinckrodt, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for iothalamate meglumine
US Patents:0
Tradenames:5
Applicants:2
NDAs:4
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 19
Patent Applications: 720
What excipients (inactive ingredients) are in iothalamate meglumine?iothalamate meglumine excipients list
DailyMed Link:iothalamate meglumine at DailyMed
Pharmacology for iothalamate meglumine
Medical Subject Heading (MeSH) Categories for iothalamate meglumine

US Patents and Regulatory Information for iothalamate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt VASCORAY iothalamate meglumine; iothalamate sodium INJECTABLE;INJECTION 016783-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Liebel-flarsheim CYSTO-CONRAY II iothalamate meglumine SOLUTION;INTRAVESICAL 017057-002 Approved Prior to Jan 1, 1982 RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Liebel-flarsheim CONRAY 30 iothalamate meglumine INJECTABLE;INJECTION 016983-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Liebel-flarsheim CONRAY 43 iothalamate meglumine INJECTABLE;INJECTION 013295-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.